These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3086051)

  • 1. Streptococcus faecalis: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1986; 32(3):270-85. PubMed ID: 3086051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterococcus faecalis: in vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against high-level-gentamicin-resistant isolates.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1993; 39(4):248-53. PubMed ID: 8325126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity and killing rate of serum against gram-positive cocci in volunteers receiving imipenem, oxacillin, vancomycin or ampicillin plus gentamicin.
    Van der Auwera P; Van Laethem Y; Klastersky J
    J Antimicrob Chemother; 1987 Aug; 20(2):239-49. PubMed ID: 3478329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin- and methicillin-resistant Staphylococcus aureus: in vitro susceptibility to antimicrobial drugs.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1987; 33(5):361-75. PubMed ID: 3665635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative killing activity and postantibiotic effect of streptomycin combined with ampicillin, ciprofloxacin, imipenem, piperacillin or vancomycin against strains of Streptococcus faecalis and Streptococcus faecium.
    Fuursted K
    Chemotherapy; 1988; 34(3):229-34. PubMed ID: 3138078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased bactericidal activity as documented by serum bactericidal titers for a triple combination of cell wall active agents against gentamicin-resistant enterococci.
    Antony SJ; Matherin P; Stratton C
    Scand J Infect Dis; 1995; 27(4):401-3. PubMed ID: 8658079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo antibacterial activities of TOC-50, a new parenteral cephalosporin, against Enterococcus faecalis.
    Nomura S; Hanaki H; Furukawa T; Unemi N
    Chemotherapy; 1996; 42(6):432-8. PubMed ID: 8957577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(4):284-97. PubMed ID: 3145172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Enterococcus faecalis clinical isolates with 'penicillin-resistant, ampicillin-susceptible' phenotype as reported by Vitek-2 Compact system.
    Tan YE; Ng LS; Tan TY
    Pathology; 2014 Oct; 46(6):544-50. PubMed ID: 25158809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Enterococcus faecalis and E. faecium: comparison of Mueller-Hinton, Iso-Sensitest, and Wilkins-Chalgren agar media.
    Traub WH; Geipel U; Leonhard B
    Chemotherapy; 1998; 44(4):217-29. PubMed ID: 9681198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
    Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
    J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.
    Kim MJ; Weiser M; Gottschall S; Randall EL
    J Clin Microbiol; 1987 May; 25(5):787-90. PubMed ID: 3108309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides.
    Aznar J; García Iglesias MC; Perea EJ
    J Antimicrob Chemother; 1984 Feb; 13(2):129-32. PubMed ID: 6423613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
    Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
    Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
    Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Acinetobacter calcoaceticus to antimicrobial drugs, alone and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1989; 35(2):95-104. PubMed ID: 2758872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci.
    Itokazu GS; Nathan C; Hariharan R; Kostman JR; Kabins SA; Weinstein RA
    Chemotherapy; 1996; 42(4):235-9. PubMed ID: 8804789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.